Veterinary Medicines

MILOXAN, Injekční suspenze

Authorised
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium sordellii, toxoid
Download as PDF

Product identification

Medicine name:
MILOXAN, Injekční suspenze
Active substance:
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium sordellii, toxoid
Target species:
  • Goat
  • Pig
  • Sheep
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    1.00
    Dose
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    1.00
    Dose
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    1.00
    Dose
  • Clostridium chauvoei, Inactivated
    90.00
    percent
    /
    1.00
    Dose
  • Clostridium sordellii, toxoid
    90.00
    percent
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • USKVBL
Authorisation number:
  • 97/181/98-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."